APPLICATION
ANDA212944
TYPE
ANDA
ORIGINAL APPROVAL
2022-08-05
LATEST ACTION
2023-07-21
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
VASOPRESSINPrescription
VASOPRESSIN 20UNITS/ML (20UNITS/ML) · SOLUTION · INTRAVENOUS
Approval history
2023-07-21Labeling · Supplement 2 · standardAP
2022-08-05UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.